Fenebrutinib Promises MS Breakthrough, Weather Triggers Tough Pain Days, Oregon Nanoagent Eradicates Tumors Safely, Brain Signals Drive Overeating, and more...

(0:10): Genentech's Fenebrutinib Shows Promising Results as Potential First Oral BTK Inhibitor for MS(2:14): University Study Links Weather to Arthritis Pain, Predicts 'Tougher Pain Days' with Low-Pressure Systems(4:10): Oregon State's Iron-Based Nanoagent Shows Promise in Tumor Eradication Without Toxicity(5:50): Study Reveals Brain's Hidden Signals Fuel Overeating Despite Fullness, Highlighting Obesity Challenges(7:21): New Study Uncovers Brain's Role in Chronic Pain and Anxiety, Reveals Potential Treatment TargetTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Is the cold weather affecting my arthritis? - PA Media : PA Media